Skip to main content
. Author manuscript; available in PMC: 2023 Jun 14.
Published in final edited form as: Immunity. 2022 Dec 28;56(1):107–124.e5. doi: 10.1016/j.immuni.2022.12.002

Figure 4. Tumor-specific CD8+ T cells only acquire effector phenotype after migration into the tumor.

Figure 4.

(A) Experimental setup for P14 transfers to study kinetics of tumor infiltration. Analysis of P14 phenotype in both TRAMPC1-GP and B16-GP tumors over the time course. P14s gated on CD44+PD1+.

(B) Summaries of total P14s in TRAMPC1-GP TDLNs and tumors over time course.

(C) Representative flow cytometry of intracellular cytokine staining (ICCS) of IFNγ and TNF-α, gated on CD44+PD1+ P14s.

(D) Experimental setup for P14 TDLN re-transfer into tumor-matched mice.

(E) Flow cytometry gating of re-transferred P14s in TDLNs and tumors of congenically mismatched recipients.

(F) Analysis of phenotype of re-transferred P14s.

(G and H) Summary plot of CD62L (G) and GzmB (H) expression of re-transferred P14s. Different shapes (circle/square/triangle) indicate to which of the 3 separate experiments each sample belongs.

(I) Heatmap of Z scored log2 expression of genes in naive P14s, sorted activated P14s D7 post transfer from TRAMPC1-GP TDLNs, endogenous tumor-stem-like CD8s, and endogenous TD CD8s.

(J) PCA of T cell subsets.

(K) Analysis of differentially methylated regions, using previously defined cluster of genes demethylated in P14s from LCMV Arm (cluster 1, Figure 3G). Plot shows cluster 1 differentially methylated regions’ T cells from various conditions.

(L) Specific methylation changes in Gzmb and Ifng. Traces show total methylation from 0% to 100% in regions near both genes. Boxed regions show significantly differentially methylated regions. Dot plots show methylation of each CpG in boxed region. Median and 95% confidence intervals (CIs) are shown. *p < 0.05 determined by Mann-Whitney test.